UNITED States health officials Saturday (Sunday in Manila) agreed to allow emergency use of a second antibody drug to help the immune system fight Coronavirus disease 2019 (Covid-19), an experimental medicine that President Donald Trump was given when he was sickened last month.
The Food and Drug Administration (FDA) authorized use of the Regeneron Pharmaceuticals Inc. drug to try to prevent hospitalization and worsening disease from developing in patients with mild-to-moderate symptoms.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.